The White House announced plans to expand the TrumpRx prescription drug discount program, with President Trump claiming the number of available medications will increase by nearly sevenfold to over 600 drugs.

The expansion announcement comes after experts earlier this year questioned the limited scope of medications initially available through the TrumpRx website, noting that the original selection would serve only a relatively small patient population.

Reports indicate that businessman Mark Cuban will be involved in the program's expansion, though specific details about his role have not been disclosed. The TrumpRx platform was designed to provide discounted prescription medications to Americans facing high drug costs.

The timing and implementation details of the expansion have not been fully outlined by the administration. The original TrumpRx program launched as part of broader efforts to address prescription drug affordability, a issue that has affected millions of Americans struggling with medication costs.

The announcement represents one of the administration's latest initiatives targeting healthcare costs, though the specific mechanisms for achieving the claimed price reductions and drug availability increases remain to be detailed by program administrators.